Efficacy and Safety of Anti-SARS-CoV-2 Antiviral Agents and Monoclonal Antibodies in Patients with SLE: A Case-Control Study.

Biomolecules · 2023 · PMC10527378 · PMID 37759674

Europe PMC DOI

hedged sentence

0.1870

closest p · 3.7× alpha

0.1870

boldest claim

The sentences

showed a trendp = 0.187not close (p > 0.1)

Accordingly, treated subjects were taking higher prednisone-equivalent doses at time of COVID-19 diagnosis [5 (0–10) mg/day] than untreated subjects [0 (0–2.5) mg/day; p = 0.002] and showed a trend towards a higher frequency of concomitant immunosuppressant treatment (67% vs. 48%; p = 0.187].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.